BETHANY AGUILAR: Open Payments
NPI 1710569082 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,356 in 65 payments from 18 companies in 2025. Trend: 2023 $264 · 2024 $133 · 2025 $1,356
Food & beverage: $1,271Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $274 |
| UCB, Inc. | 10 | $158 |
| PFIZER INC. | 6 | $144 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $141 |
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| Lilly USA, LLC | 3 | $79 |
| LEO Pharma Inc. | 4 | $66 |
| GENZYME CORPORATION | 2 | $63 |
| Galderma Laboratories, L.P. | 2 | $58 |
| LNHC, Inc | 2 | $46 |
Products named: TREMFYA, Bimzelx, CIBINQO, DUPIXENT, NEMLUVIO, ILUMYA, EBGLYSS, COSENTYX.
Industry payments across FL — which companies pay providers there.
